Methods to identify modulators of actin-binding proteins
AssigneeRegents of the University of Minnesota
InventorsAdam William Avery, Thomas S. Hays, David D. Thomas, Michael E. Fealey, Robyn T. Rebbeck
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for identifying compounds that cause structural changes in a protein bound to an actin filament. The methods include the use of cells that include two actin-binding proteins, each labeled with a chromophore, and exposing the cells to a test compound. The method further includes detecting a change in fluorescence resonance energy transfer (FRET) between the chromophores.
Claims20
A method for identifying a compound that alters fluorescence resonance energy transfer (FRET) of a protein comprising:
- providing a genetically engineered cell comprising a first protein and a second protein,
- wherein the first protein comprises a first heterologous domain that comprises a first probe, and the first protein comprises either a CH domain-containing actin-binding domain or a tandem-CH, actin-binding domain,
- wherein the second protein comprises a second heterologous domain that comprises a second probe;
- wherein each protein binds to an actin filament in the cell in a spatial proximity to result in detectable FRET between the first and second probes;
- contacting the cell with a test compound to form a mixture;
- and
- measuring the fluorescence lifetime of the first probe, the second probe, or the combination thereof
The method of claim 20 wherein the disease is spinocerebellar ataxia type 5.
The method of claim 20 wherein the mutation is L253P.
Dependencies are inferred from the claim text.